Hyperphosphatemia in chronic kidney disease exacerbates atherosclerosis via a mannosidases-mediated complex-type conversion of SCAP N-glycans
- 22 February 2021
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 99 (6), 1342-1353
- https://doi.org/10.1016/j.kint.2021.01.016
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Dietary Phosphate Modulates Atherogenesis and Insulin Resistance in Apolipoprotein E Knockout Mice—Brief ReportArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Advanced glycation end products (AGEs) increase human mesangial foam cell formation by increasing Golgi SCAP glycosylation in vitroAmerican Journal of Physiology-Renal Physiology, 2011
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialThe Lancet, 2011
- An update on the lipid nephrotoxicity hypothesisNature Reviews Nephrology, 2009
- Rosuvastatin and Cardiovascular Events in Patients Undergoing HemodialysisThe New England Journal of Medicine, 2009
- Serum Phosphorus Levels Associate with Coronary Atherosclerosis in Young AdultsJournal of the American Society of Nephrology, 2009
- Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout miceJournal of Hepatology, 2008
- Sevelamer Prevents Uremia-Enhanced Atherosclerosis Progression in Apolipoprotein E–Deficient MiceJournal of the American College of Cardiology, 2005
- Golgi α-mannosidase II deficiency in vertebrate systems: implications for asparagine-linked oligosaccharide processing in mammalsBiochimica et Biophysica Acta (BBA) - General Subjects, 2002
- Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation11See Editorial by van Zonneveld and Rabelink, p. 2037Kidney International, 2001